184 related articles for article (PubMed ID: 30366349)
1. Osteocytes.
Rupp M; Merboth F; Daghma DE; Biehl C; El Khassawna T; Heiß C
Z Orthop Unfall; 2019 Apr; 157(2):154-163. PubMed ID: 30366349
[TBL] [Abstract][Full Text] [Related]
2. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?
Sapir-Koren R; Livshits G
Osteoporos Int; 2014 Dec; 25(12):2685-700. PubMed ID: 25030653
[TBL] [Abstract][Full Text] [Related]
3. The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases.
Pathak JL; Bravenboer N; Klein-Nulend J
Front Endocrinol (Lausanne); 2020; 11():405. PubMed ID: 32733380
[TBL] [Abstract][Full Text] [Related]
4. [Osteocytes and Wnt signaling.].
Fukumoto S
Clin Calcium; 2019; 29(3):317-321. PubMed ID: 30814376
[TBL] [Abstract][Full Text] [Related]
5. Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy.
Toscani D; Bolzoni M; Ferretti M; Palumbo C; Giuliani N
Front Immunol; 2018; 9():2467. PubMed ID: 30410490
[TBL] [Abstract][Full Text] [Related]
6. [Bone and Nutrition. Sclerostin and bone metabolism].
Tatsumi S; Nagamoto K; Ogata M; Miyamoto K
Clin Calcium; 2015 Jul; 25(7):1043-7. PubMed ID: 26119318
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte.
Wang T; Yu X; He C
Curr Drug Targets; 2019; 20(1):1-15. PubMed ID: 29618305
[TBL] [Abstract][Full Text] [Related]
8. A review of osteocyte function and the emerging importance of sclerostin.
Compton JT; Lee FY
J Bone Joint Surg Am; 2014 Oct; 96(19):1659-68. PubMed ID: 25274791
[TBL] [Abstract][Full Text] [Related]
9. The Osteocyte: New Insights.
Robling AG; Bonewald LF
Annu Rev Physiol; 2020 Feb; 82():485-506. PubMed ID: 32040934
[TBL] [Abstract][Full Text] [Related]
10. How much do we know about the role of osteocytes in different phases of fracture healing? A systematic review.
Choy MHV; Wong RMY; Chow SKH; Li MC; Chim YN; Li TK; Ho WT; Cheng JCY; Cheung WH
J Orthop Translat; 2020 Mar; 21():111-121. PubMed ID: 32309136
[TBL] [Abstract][Full Text] [Related]
11. Bone remodeling in the context of cellular and systemic regulation: the role of osteocytes and the nervous system.
Niedźwiedzki T; Filipowska J
J Mol Endocrinol; 2015 Oct; 55(2):R23-36. PubMed ID: 26307562
[TBL] [Abstract][Full Text] [Related]
12. Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.
Kalaitzoglou E; Popescu I; Bunn RC; Fowlkes JL; Thrailkill KM
Curr Osteoporos Rep; 2016 Dec; 14(6):310-319. PubMed ID: 27704393
[TBL] [Abstract][Full Text] [Related]
13. The Bromodomain Inhibitor
Siegenthaler B; Ghayor C; Gjoksi-Cosandey B; Ruangsawasdi N; Weber FE
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30366476
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin: recent advances and clinical implications.
Honasoge M; Rao AD; Rao SD
Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):437-46. PubMed ID: 25333305
[TBL] [Abstract][Full Text] [Related]
15. [Pathophysiology of bone metabolism].
Jakob F; Seefried L; Ebert R
Internist (Berl); 2008 Oct; 49(10):1159-60, 1162, 1164 passim. PubMed ID: 18810375
[TBL] [Abstract][Full Text] [Related]
16. Mature primary human osteocytes in mini organotypic cultures secrete FGF23 and PTH1-34-regulated sclerostin.
Knowles HJ; Chanalaris A; Koutsikouni A; Cribbs AP; Grover LM; Hulley PA
Front Endocrinol (Lausanne); 2023; 14():1167734. PubMed ID: 37223031
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes.
Brabnikova Maresova K; Pavelka K; Stepan JJ
Calcif Tissue Int; 2013 Apr; 92(4):354-61. PubMed ID: 23247536
[TBL] [Abstract][Full Text] [Related]
18. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
Sapir-Koren R; Livshits G
Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
[TBL] [Abstract][Full Text] [Related]
19. Osteocyte recruitment declines as the osteon fills in: interacting effects of osteocytic sclerostin and previous hip fracture on the size of cortical canals in the femoral neck.
Power J; Doube M; van Bezooijen RL; Loveridge N; Reeve J
Bone; 2012 May; 50(5):1107-14. PubMed ID: 22353552
[TBL] [Abstract][Full Text] [Related]
20. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts.
Han Y; You X; Xing W; Zhang Z; Zou W
Bone Res; 2018; 6():16. PubMed ID: 29844945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
